- Cyclerion Therapeutics Inc Clinical Data Update from Study of CY6463 in CIAS Webinar TranscriptJul 28, 2022
- Cyclerion Therapeutics Inc Call to Discuss CY6463 MELAS Clinical Data TranscriptJun 28, 2022
- Cyclerion Therapeutics Inc Pipeline Update Webinar Corporate Call TranscriptApr 27, 2021
- Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Cyclerion Therapeutics, Inc. - Special Call TranscriptOct 14, 2020
- Cyclerion Therapeutics, Inc. - Special Call TranscriptJul 09, 2020
- Cyclerion Therapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Cyclerion Therapeutics, Inc. - Special Call TranscriptOct 30, 2019
- Cyclerion Therapeutics Inc Investor Webcast Event TranscriptSep 17, 2019
- Cyclerion Therapeutics Inc Corporate Overview Call TranscriptMay 13, 2019
Cyclerion Therapeutics Inc Investor Webcast Event Transcript
Good morning everyone and welcome to Cyclerion's investor event focused on Praliciguat in diabetic nephropathy and heart failure with preserved ejection fraction. My name is Jessi Rennekamp. And I work in Cyclerion's Investor Relations and Corporate Communications Department.
We're really excited that you could be here with us today either in person or for those of you on the webcast.
Throughout today's presentation, we will be making forward-looking statements including statements about the timing and potential results of our clinical trials. These statements are based on current expectations and actual results could differ. For more information, please see the risk factors section of our SEC filings on our website, www.cyclerion.com.
We've put together an exciting agenda for today. The event will run until about 10 a.m. with time for Q&A at the end. If you're on the webcast and would like to ask a question,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)